- Tytuł:
- Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
- Autorzy:
- Źródło:
- The Lancet; April-May 2022, Vol. 399 Issue: 10336 p1695-1707, 13p
Periodyk